J&J is pausing recruitment for its clinical trial of a coronavirus disease 2019 vaccine; racial bias found in algorithms used nationwide in health-cost analytics software; Americans stockpile food and other essentials amid resurging pandemic fears.
Announced yesterday, Johnson & Johnson (J&J) said it is temporarily pausing recruitment and dosing for its coronavirus disease 2019 (COVID-19) vaccine candidate clinical trial after an unexplained illness in a study participant. Reported by POLITICO, the case, part of J&J’s phase 3 ENSEMBLE trial, is being reviewed by the independent drug safety monitoring board, with no further information on the patient being released. The company cautioned that adverse events, even serious ones, typically occur in any clinical study.
Reported today, a STAT investigation found that a common method of using analytics software is infusing racial bias into decision-making on who should receive stepped-up care. The study, which analyzed medical services targeted to patients who need them most, additionally found multiple algorithms across several hospitals in the United States, signaling a systemic issue as opposed to a singular event. Researchers note that the bias can produce significant differences in assessing patients’ need for special care to manage conditions like hypertension and diabetes.
Reported by USA Today, amid reports of surges in COVID-19 cases nationwide, slightly more than half of Americans said in a recent poll they have or plan to stockpile food and other essentials. Principal reasons for this include the millions who continue to work or attend school remotely, as well as fears of a resurgent pandemic. As of October 2, COVID-19 cases in the United States were at their highest in almost 2 months, and in the past week, the average grocery bill has risen 11%.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More